Pancreatic Cancer Research

ResearcherWestern UniversityActive in the last 2 years

Emilie Jaune

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5787-0803; OpenAlex author ID A5085216597. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. EZH2 deletion does not affect acinar regeneration but restricts progression to pancreatic cancer in mice. Co-author DOI 10.1172/jci.insight.173746↗
  2. Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. Co-author DOI 10.15252/embj.2021110466↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nelson Dusetti · 2 shared papers, 2022–2024 · strength 0.28
  2. Abdessamad El Kaoutari · 1 shared paper, 2024 · strength 0.17
  3. Fatemeh Mousavi · 1 shared paper, 2024 · strength 0.17
  4. Raul A. Urrutia · 1 shared paper, 2024 · strength 0.17
  5. Gwen Alyce Lomberk · 1 shared paper, 2024 · strength 0.17
  6. Christopher L. Pin · 1 shared paper, 2024 · strength 0.17
  7. Fabienne Guillaumond · 1 shared paper, 2022 · strength 0.11
  8. Evan Chen Lien · 1 shared paper, 2022 · strength 0.11
  9. François Bertucci · 1 shared paper, 2022 · strength 0.11
  10. Tristan Gicquel · 1 shared paper, 2022 · strength 0.11
  11. Sophie Vasseur · 1 shared paper, 2022 · strength 0.11
  12. Victoire Gouirand · 1 shared paper, 2022 · strength 0.11
  13. Julie Leca · 1 shared paper, 2022 · strength 0.11
  14. Jared R. Mayers · 1 shared paper, 2022 · strength 0.11
  15. Richard Tomasini · 1 shared paper, 2022 · strength 0.11
  16. Jérémy Nigri · 1 shared paper, 2022 · strength 0.11
  17. Matthew G. Vander Heiden · 1 shared paper, 2022 · strength 0.11
  18. Juan Iovanna · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.